Procter & Gamble Health Limited (BOM:500126)
India · Delayed Price · Currency is INR 5,545.00
-58.30 (-1.04%)
At close: Nov 6, 2026
Procter & Gamble Health Market Cap
Procter & Gamble Health has a market cap or net worth of 92.04 billion as of November 6, 2026. It is the 10,024th most valuable company in the world and the 618th biggest in India. Its market cap has decreased by 8.46% in one year.
Market Cap
92.04B
Enterprise Value
88.83B
Revenue
14.89B
Global Rank
Country Rank
#618 India
PE Ratio
24.23
ChartMarket Cap Chart
Since June 14, 1999, Procter & Gamble Health's market cap has increased from 9.75B to 92.04B, an increase of 844.44%. That is a compound annual growth rate of 8.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 92.04B | -2.74% |
| Dec 31, 2025 | 94.63B | 8.85% |
| Dec 31, 2024 | 86.94B | 5.90% |
| Dec 29, 2023 | 82.10B | 23.12% |
| Dec 30, 2022 | 66.69B | -24.14% |
| Dec 31, 2021 | 87.91B | -22.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Granules India | 196.87B |
| Caplin Point Laboratories | 184.14B |
| AstraZeneca Pharma India | 157.37B |
| Jubilant Pharmova | 149.98B |
| Viyash Scientific | 102.79B |
| Sanofi India | 77.83B |
| Bliss GVS Pharma | 67.07B |
| FDC Limited | 63.76B |